TickerFactsScreenerDevelopers

Solid Biosciences Inc. (SLDB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$20.12M2017: -$43.22M2018: -$70.20M2019: -$92.71M2020: -$56.60M2021: -$77.76M2022: -$97.98M2023: -$94.18M2024: -$100.01M2025: -$156.29M-$156.29M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$156.29M-56.3%
2024-$100.01M-6.2%
2023-$94.18M+3.9%
2022-$97.98M-26.0%
2021-$77.76M-37.4%
2020-$56.60M+39.0%
2019-$92.71M-32.1%
2018-$70.20M-62.4%
2017-$43.22M-114.8%
2016-$20.12M—